Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

PFIZER LTD. - 500680 - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Re-Appointment Of Mr. S. Sridhar As The Managing Director

 Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company has at their Meeting held today re-appointed Mr. S. Sridhar (DIN: 05162648) as the Managing Director of the Company for a further period of 5 years with effect from March 18, 2021. The re-appointment of Mr. S. Sridhar will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company. The covering letter including profile of Mr. S Sridhar is attached herewith.
05-02-2021
Bigul

PFIZER LTD. - 500680 - Unaudited Financial Results For The Quarter Ended December 31, 2020.

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended December 31, 2020, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.30 p.m. and concluded at 4.00 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record.
05-02-2021
Bigul

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

 As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine
04-02-2021
Bigul

Pfizer expects to earn about $15 billion from Covid-19 vaccine sale in 2021

 In releasing its fourth-quarter earnings, Pfizer also forecast 2021 sales between $59.4 billion and $61.4 billion. The company raised its full-year earnings guidance to between $3.10 to $3.20 from $3 to $ 3.10 earlier
03-02-2021
Bigul

AstraZeneca hopes for Japan's approval of COVID-19 vaccine as soon as mid-Feb

 AstraZeneca Plc started domestic vaccine trials last summer, it fell behind its rival Pfizer Inc in the schedule to inoculate the Japanese public after Pfizer sought government approval in December
29-01-2021

Pfizer-BioNTech say their COVID vaccine works against UK, South Africa variants

 In a statement, the two companies said the "small differences" detected in tests comparing the original virus and the recent versions "are unlikely to lead to a significant reduction in the effectiveness of the vaccine".
28-01-2021
Bigul

Five or six doses? Controversy over Pfizer Covid-19 vaccine vials

 The difficulty in obtaining that sixth dose in practice means many countries are at loggerheads with Pfizer and facing a drop in supply.
27-01-2021
Bigul

PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended December 31, 2020.

 PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 5, 2021, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2020. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Thursday, December 31, 2020 (close of business) till 48 hours after the results are made public on February 5, 2021. We request you to kindly take the same on record.
27-01-2021
Bigul

Pfizer working on booster shot to protect against Covid-19 variants

 "We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to Reuters
27-01-2021

Pfizer, Moderna COVID-19 vaccines could possibly be available in India through COVAX route

 India is eligible to get COVID-19 vaccines from COVAX for vaccinating about 20 percent of its population.
25-01-2021
Next Page
Close

Let's Open Free Demat Account